Pre-operative coronary revascularization: An optimal therapy for high-risk vascular surgery patients?

Acta Anaesthesiologica Scandinavica

Volumn 50, Issue 7, 2006, Pages 816-827

  Kertai, M D ^a,b   Bogar, L ^c   Gal, J ^a   Poldermans, D ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cardiac risk reduction; Coronary revascularization; Percutaneous coronary intervention; Vascular surgery

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THALLIUM;

ABDOMINAL AORTA ANEURYSM; ANGINA PECTORIS; BLEEDING; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; ELECTIVE SURGERY; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MEDICAL CARE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; TACHYCARDIA; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VASCULAR SURGERY;

HUMANS; INTRAOPERATIVE COMPLICATIONS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; VASCULAR SURGICAL PROCEDURES;

EID: 33745859428     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2006.01067.x     Document Type: Review

References (48)

1. Kertai MD, Klein J, van Urk H, Bax JJ, Poldermans D. Cardiac complications after elective major vascular surgery. Acta Anaesthesiol Scand 2003; 47: 643-54.
2. Hertzer NR, Beven EG, Young JR, O'Hara PJ, Ruschhaupt WF, III, Graor RA et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984; 199: 223-33.
3. Fleischmann KE, Goldman L, Young B, Lee TH. Association between cardiac and noncardiac complications in patients undergoing non-cardiac surgery: outcomes and effects on length of stay. Am J Med 2003; 115: 515-20.
4. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351: 2795-804.
5. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-84.
6. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 1996; 57: 37-44.
7. Cohen MC, Aretz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 1999; 8: 133-9.
8. Warltier DC, Pagel PS, Kersten JR. Approaches to the prevention of perioperative myocardial ischemia. Anesthesiology 2000; 92: 253-9.
9. Poldermans D, Boersma E, Bax JJ, Kliffen M, van Urk H, van de Ven LL et al. Correlation of location of acute myocardial infarct after noncardiac vascular surgery with preoperative dobutamine echocardiographic findings. Am J Cardiol 2001; 88: 1413-4.
10. Muller JE, Kaufmann PG, Luepker RV, Weisfeldt ML, Deedwania PC, Willerson JT. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants. Circulation 1997; 96: 3233-9.
11. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664-72.
12. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of the Perioperative Ischemia Research Group. N Engl J Med 1996; 335: 1713-20.
13. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789-94.
14. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349-61.
15. Poldermans D, Bax JJ, Kertai MD, Krenning B, Westerhout CM, Schinkel AFL et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003; 107: 1848-51.
16. Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM. Lipid-lowering therapy and in-hospital mortality following major non-cardiac surgery. JAMA 2004; 291: 2092-9.
17. Priebe HJ. Perioperative myocardial infarction-aetiology and prevention. Br J Anaesth 2005; 95: 3-19.
18. Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B et al. Multifactorial index of cardiac risk in non-cardiac surgical procedures. N Engl J Med 1977; 297: 845-50.
19. Detsky AS, Abrams HB, McLaughlin JR, Drucker DJ, Sasson Z, Johnston N et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986; 1: 211-9.
20. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989; 110: 859-66.
21. L'Italien GJ, Paul SD, Hendel RC, Leppo JA, Cohen MC, Fleisher LA et al. Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1,081 vascular surgical candidates. J Am Coll Cardiol 1996; 27: 779-86.
22. Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001; 285: 1865-73.
23. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major non-cardiac surgery. Circulation 1999; 100: 1043-9.
24. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in non-cardiac surgery: scientific review. JAMA 2002; 287: 1435-44.
25. Hertzer NR, Young JR, Beven EG, O'Hara PJ, Graor RA, Ruschhaupt WF et al. Late results of coronary bypass in patients presenting with lower extremity ischemia: the Cleveland Clinic Study. Ann Vasc Surg 1987; 1: 411-9.
26. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of non-cardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation 1997; 96: 1882-7.
27. Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative-and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the Medicare population. Anesth Analg 1999; 89: 849-55.
28. Hassan SA, Hlatky MA, Boothroyd DB, Winston C, Mark DB, Brooks MM et al. Outcomes of non-cardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med 2001; 110: 260-6.
29. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE et al. ACC/AHA guidelines update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105: 1257-67.
30. Back MR, Stordahl N, Cuthbertson D, Johnson BL, Bandyk DF. Limitations in the cardiac risk reduction provided by coronary revascularization prior to elective vascular surgery. J Vasc Surg 2002; 36: 526-33.
31. Landesberg G, Mosseri M, Wolf YG, Bocher M, Basevitch A, Rudis E et al. Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery. Circulation 2003; 108: 177-83.
32. Rihal CS, Sutton-Tyrrell K, Guo P, Keller NM, Jandova, Sellers MA et al. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the Bypass Angioplasty Revascularization Investigation. Circulation 1999; 100: 171-7.
33. Allen JR, Helling TS, Hartzler GO. Operative procedures not involving the heart after percutaneous transluminal coronary angioplasty. Surg Gynecol Obstet 1991; 173: 285-8.
34. Elmore JR, Hallett JW Jr, Gibbons RJ, Naessens JM, Bower TC, Cherry KJ et al. Myocardial revascularization before abdominal aortic aneurysmorrhaphy: effect of coronary angioplasty. Mayo Clin Proc 1993; 68: 637-41.
35. Gottlieb A, Banoub M, Sprung J, Levy PJ, Beven M, Mascha EJ. Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneous transluminal coronary angioplasty. J Cardiothorac Vasc Anesth 1998; 12: 501-6.
36. Posner KL, Van Norman GA, Chan V. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth Analg 1999; 89: 553-60.
37. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ et al. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Coronary Angioplasty). J Am Coll Cardiol 2001; 37: 2215-38.
38. Godet G, Riou B, Bertrand M, Fleron MH, Goarrin JP, Montalescot G et al. Does preoperative coronary angioplasty improve perioperative cardiac outcome? Anesthesiology 2005; 102: 739-16.
39. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35: 1288-94.
40. Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlcoker T, Charnoff NE et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42: 234-10.
41. Reddy PR, Vaitkus PT. Risks of non-cardiac surgery after coronary stenting. Am J Cardiol 2005; 95: 755-7.
42. Pierpont GL, Moritz TE, Goldman S, Krupski WC, Littooy F, Ward HB et al. Disparate opinions regarding indications for coronary artery revascularization before elective vascular surgery. Am J Cardiol 2004; 94: 1124-8.
43. Moscucci M, Eagle KA. Coronary revascularization before noncardiac surgery. N Engl J Med 2006; 351: 2861-3.
44. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in non-acute coronary artery disease: a meta-analysis. Circulation 2005; 111: 2906-12.
45. Eagle KA, Singer DE, Brewster DC, Darling RC, Mulley AG, Boucher CA. Dipyridamole-thallium scanning in patients undergoing vascular surgery. Optimizing preoperative evaluation of cardiac risk. JAMA 1987; 257: 2185-9.
46. Prinssen M, Verhoeven ELG, Buth J, Cuypers PWM, van Sambeek MRHM, Balm R et al. The Dutch Randomized Endovascular Aneurysm Management (DREAM) Trial Group. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 2004; 351: 1607-18.
47. Blankensteijn JD, de Jong SECA, Prinssen M, van der Harm AC, Buth J, van Sterkenburg SMM et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med 2005; 352: 2398-405.
48. Devereaux PJ, Beattie WS, Choi PT-L, Badner NH, Guyatt GH, Villar JC et al. How strong is the evidence for the use of perioperative beta-blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005; 331: 313-21.